Description

EXODUS T-2800 – Large-Scale, Fully Automatic Exosome Isolation System, GMP-Compliant

Introduction

EXODUS T-2800 is a large-scale, fully automatic exosome isolation system that integrates the entire workflow from sample pre-processing, isolation, to collection. Based on proprietary ultrasonic nano-filtration technology, the T-2800 provides a robust solution for exosome production in therapeutics, drug delivery, and regenerative medicine. The system is designed to meet industrial-scale manufacturing, ensuring high-purity exosomes with excellent yield, reproducibility, and strict compliance with Good Manufacturing Practices (GMP).

Operating Principle

EXODUS T-2800 combines Negative Pressure Oscillation (NPO) and Double-Coupled Ultrasonic Harmonic Oscillation (HO) to efficiently remove impurities such as free proteins and nucleic acids, enabling the recovery of exosomes that are pure, sterile, and endotoxin-free.

Key Technical Advantages

• Three-in-one system: Integrates pre-processing, isolation, and automatic recovery in a single unit with simple operation.
• Outstanding purity and yield: Removes >99% proteins; particle-to-protein ratio >5×10⁸ particles/µg protein; exosome concentration >10¹¹ particles/mL.
• Reliable quality: Isolated exosomes are sterile, endotoxin-free, and meet safety standards.
• Stable and controllable: Fully automated process with real-time monitoring, ensuring batch-to-batch reproducibility.
• Safe & compliant: Single-use sterile consumables meeting pharmacopeial standards; software complies with GMP and 21 CFR Part 11.

Typical Applications

• High-purity exosome production from mesenchymal stem cells (MSC) (>99.8% protein removal).
• Drug delivery, extracellular vesicle-based therapies, and regenerative medicine.
• Biopharmaceutical and cell therapy manufacturing centers requiring industrial scale and GMP compliance.

Key Specifications

• Processing volume: 1 – 10 L
• Processing speed: 1 – 2 L/hour
• Concentration factor: ≥100-fold (adjustable)
• Protein removal efficiency: >99%
• Particle-to-protein ratio: >5×10⁸ particles/µg protein
• Exosome concentration: 10¹¹–10¹² particles/mL (depending on sample and program)
• Display: 10.4” touch screen with real-time monitoring
• Dimensions: 820 × 500 × 685 mm; Weight: ≤90 kg

Conclusion

With cutting-edge technology and design optimized for large-scale manufacturing, EXODUS T-2800 is the ideal choice for research centers and cell/exosome therapy facilities aiming to achieve international GMP standards. Biogroup is proud to be the official distributor of EXODUS in Vietnam, committed to delivering comprehensive solutions for exosome research and production.